Advisory Services Network’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Advisory Services Network’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-350	Closed	-$3K	–	3173
2020 Q4	$3K	Buy	+350	New	+$2.75K	﹤0.01%	2954
2020 Q2	–	Sell	-4,000	Closed	-$38K	–	2946
2020 Q1	$38K	Sell	4,000 -2,000	-33%	-$23.9K	﹤0.01%	1523
2019 Q4	$86K	Buy	+6,000	New	+$87.5K	﹤0.01%	1228

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's OPNT Position: Q1 2021 in Review

Advisory Services Network sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2021, closing a stake of 350 shares — an estimated $3K sold.

Advisory Services Network first reported a position in OPNT in Q4 2019 and held it in 3 quarters. The position peaked at $86K in Q4 2019. 31 funds tracked by Wall St. Rank hold OPNT as of Q1 2021.

Advisory Services Network reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Advisory Services Network sold 350 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $3K.
Advisory Services Network first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
Advisory Services Network's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $86K in Q4 2019.
31 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.